DOJ Orders Immediate Reclassification of Medical Marijuana Products
The U.S. Department of Justice (DOJ) has reclassified certain marijuana and marijuana-containing products to Schedule III controlled substances, which recognizes a drug’s potential legitimate medical use, a significant change in federal drug policy that could have implications for employers and workplace drug policies. Quick Hits The DOJ ordered the reclassification of certain marijuana and marijuana-containing […]
